5
Participants
Start Date
July 20, 2022
Primary Completion Date
December 1, 2023
Study Completion Date
December 1, 2023
amobarbital/Gel-One (one dose)
One dose of amobarbital/Gel-One during the initial surgical intervention
Placebo (single dose)
One dose of placebo during the initial surgical intervention
amobarbital/Gel-One (two doses)
One dose of amobarbital/Gel-One during the initial surgical intervention. A second dose will be administered during the second surgical intervention.
Placebo (two doses)
One dose of placebo during the initial surgical intervention. A second dose will be administered during the second surgical intervention.
University of Iowa, Iowa City
United States Department of Defense
FED
J L Marsh
OTHER